GeneOne Life Science Announces Full Enrollment of First-In-Human Study of MERS Vaccine

SEOUL, South Korea, Aug. 08, 2016 (GLOBE NEWSWIRE) — GeneOne Life Science Inc. (KSE:011000) today announced that enrollment has been completed of the first-in-human clinical trial of the GLS-5300 vaccine for MERS (Middle East Respiratory Syndrome) with a total of 75 subjects. GeneOne Life Science and U.S.-based Inovio Pharmaceuticals (NASDAQ:INO) are co-developing the vaccine.  This […]

Read more